Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Vertex Announces U.S. FDA Approval For TRIKAFTA To Include Additional Non-F508del TRIKAFTA-Responsive Variants
UBS Says 'Underweight the Names With High China Exposure'
J.P. Morgan's Top Healthcare Stocks for 2025
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
JMP Securities Reiterates Market Outperform on CRISPR Therapeutics, Maintains $86 Price Target
CRISPR Therapeutics Analyst Ratings